Grants per year
Search results
-
Active
Prot #GO44479: A Phase II, Open-label, Multicenter, Randomized Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Patients with Resected Pancreatic Ductal Adenocarcinoma
Mulcahy, M. F. (PD/PI)
4/26/24 → 7/1/29
Project: Research project
-
Prot #7465-CL-202: An Open-label, Multicenter, Multicohort, Phase 2 Study to Evaluate Enfortumab Vedotin in Subjects with Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
Mulcahy, M. F. (PD/PI)
Parexel, Astellas Pharma Global Development, Inc.
11/23/20 → 11/23/26
Project: Research project